Cognitive Impairment Pipeline Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: AgeneBio, Iproteos, Vicore Pharma - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cognitive Impairment - Pipeline Review, H1 2016" drug pipelines to their offering.

The report provides comprehensive information on the therapeutics under development for Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cognitive Impairment and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  • The report provides a snapshot of the global therapeutic landscape of Cognitive Impairment
  • The report reviews pipeline therapeutics for Cognitive Impairment by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report reviews key players involved Cognitive Impairment therapeutics and enlists all their major and minor projects
  • The report assesses Cognitive Impairment therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Cognitive Impairment

Companies Mentioned Include:

  • AbbVie Inc.
  • Addex Therapeutics Ltd
  • AgeneBio Inc.
  • Amarantus Bioscience Holdings, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Eli Lilly and Company
  • Ensol Biosciences Inc.
  • F. Hoffmann-La Roche Ltd.
  • FORUM Pharmaceuticals Inc.
  • Genzyme Corporation
  • H. Lundbeck A/S
  • Heptares Therapeutics Limited
  • Intra-Cellular Therapies, Inc.
  • Iproteos S.L.
  • Luc Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Tetra Discovery Partners LLC
  • Therapix Biosciences Ltd
  • Vanda Pharmaceuticals Inc.
  • Vicore Pharma AB
  • Virogenomics BioDevelopment, Inc.

For more information visit http://www.researchandmarkets.com/research/q2q25b/cognitive

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716